Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas - Concepedia

Concepedia

Publication | Open Access

Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas

DOI Full Paper Access

79

Citations

27

References

2013

Year

A. V. Salnikov, Niko P. Bretz, Claudia Perne, John Hazin, Sandro Keller, Mina Fogel, Ingrid Herr, Thomas Schlange, Gerhard Moldenhauer, Peter Altevogt

British Journal of Cancer

Abstract

Our data demonstrate that targeting of CD24 could be beneficial for the anti-cancer treatment combined with standard chemotherapy regimes.

References

	Year	Citations
Marketed therapeutic antibodies compendium Janice M. Reichert mAbs ImmunodeficienciesImmunologyPathologyImmunotherapeuticsImmunotherapy	2012	365
CD24, a Mucin-Type Glycoprotein, Is a Ligand for P-Selectin on Human Tumor Cells Silke Aigner, Zev Sthoeger, Mina Fogel, Blood	1997	324
CD24 Expression Causes the Acquisition of Multiple Cellular Properties Associated with Tumor Growth and Metastasis Petra Baumann, Natascha Cremers, Frans G. M. Kroese, Cancer Research	2005	322
CD24 mediates rolling of breast carcinoma cells on P‐selectin Silke Aigner, Carroll L. Ramos, Ali Hafezi‐Moghadam, The FASEB Journal	1998	282
Antibody-based therapeutics to watch in 2011 Janice M. Reichert mAbs ImmunologyPathologyBiological TherapyPharmacotherapyImmunotherapy	2011	234
CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor R Kay, Patricia M. Rosten, R. Keith Humphries The Journal of Immunology	1991	201
CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells Heidi Schabath, Steffen Runz, Safwan Joumaa, Journal of Cell Science Lymphocyte DevelopmentMedicineCell TraffickingImmunologyImmunoediting	2006	188
Targeting CD24 for Treatment of Colorectal and Pancreatic Cancer by Monoclonal Antibodies or Small Interfering RNA Eyal Sagiv, Alex Starr, Uri Rozovski, Cancer Research ImmunologyPathologyImmunotherapyCancer BiologyInterfering Rna	2008	162
Trial Watch: Monoclonal antibodies in cancer therapy Lorenzo Galluzzi, Erika Vacchelli, Wolf H. Fridman, OncoImmunology	2012	147
The Metastasis-Associated Gene <i>CD24</i> Is Regulated by Ral GTPase and Is a Mediator of Cell Proliferation and Survival in Human Cancer Steven C. Smith, Gary Oxford, Zhong Wu, Cancer Research	2006	146

Page 1